Real-time enrollment status for this diabetic peripheral neuropathic pain clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:38 PM UTC
| NCT Number | NCT07285018 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Peripheral Neuropathic Pain |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | July 7, 2026 (Jul 7, 2026) |
As of August 28, 2026: Clinical trial NCT07285018 is currently recruiting participants. This phase2 study for diabetic peripheral neuropathic pain is actively seeking new participants at 36 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07285018 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07285018 was last updated Jul 7, 2026 (July 7, 2026). HelloStudys verifies this status automatically.